A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH (NCT06528314)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
🩺 Plain-English Summary (8th-Grade Level)
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH.
Who can join: Review the eligibility criteria below.
Location: Akero Clinical Study Site — Birmingham, Alabama
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (329 Sites)
Showing the first 25 of 329 sites.
- Akero Clinical Study Site — Birmingham, Alabama
- Akero Clinical Study Site — Dothan, Alabama
- Akero Clinical Study Site — Chandler, Arizona
- Akero Clinical Study Site — Flagstaff, Arizona
- Akero Clinical Study Site — Peoria, Arizona
- Akero Clinical Study Site — Scottsdale, Arizona
- Akero Clinical Study Site — Tucson, Arizona
- Akero Clinical Study Site — Tucson, Arizona
- Akero Clinical Study Site — Tucson, Arizona
- Akero Clinical Study Site — Tucson, Arizona
- Akero Clinical Study Site — Conway, Arkansas
- Akero Clinical Study Site — Jonesboro, Arkansas
- Akero Clinical Study Site — Little Rock, Arkansas
- Akero Clinical Study Site — North Little Rock, Arkansas
- Akero Clinical Study Site — Coronado, California
- Akero Clinical Study Site — Escondido, California
- Akero Clinical Study Site — Folsom, California
- Akero Clinical Study Site — Fountain Valley, California
- Akero Clinical Study Site — Lancaster, California
- Akero Clinical Study Site — Long Beach, California
- Akero Clinical Study Site — Los Angeles, California
- Akero Clinical Study Site — Newport Beach, California
- Akero Clinical Study Site — Orange, California
- Akero Clinical Study Site — Pasadena, California
- Akero Clinical Study Site — Redwood City, California
📞 Contact the Study Coordinator
Phone: (650) 487-6488
Email: AkeroSynchrony@akerotx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in NASH - Nonalcoholic Steatohepatitis
- Statins for the Treatment of NASH — Rochester, Minnesota
- A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Birmingham, Alabama
- Estrogen Administration for the Treatment of NASH in Postmenopausal Women — Boston, Massachusetts
- A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Birmingham, Alabama
- Novel MRE Technique to Assess a Risk Factor for Liver Cancer — Stanford, California
- Hepatic Energy Fluxes in NASH and NAS Patients — Minneapolis, Minnesota
Explore by condition: All NASH - Nonalcoholic Steatohepatitis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.